Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy
These findings suggest that PRO is promising as a potential adjuvant therapy in combination with CAP for the treatment of CRC. Only HT-29 cells with the <i>B-RAF</i> (V600E) mutation showed promising findings in this study.
Authors
- Peter Natesan Pushparaj (ORCID: https://orcid.org/0000-0001-7574-1880)
- Mohammad Basabrain (ORCID: https://orcid.org/0000-0003-1925-0424)
- Hind Ali Alkhatabi (ORCID: https://orcid.org/0000-0002-8082-838X)
- Huda A. Al Doghaither (ORCID: https://orcid.org/0000-0002-6192-8326)
- Shiekhah Mohammad Alzahrani (ORCID: https://orcid.org/0000-0001-5222-9921)
Institutions
- King Abdulaziz University (SA)
- University of Jeddah (SA)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-27
- DOI
- https://doi.org/10.3390/cancers17091470
- Citations
- 4
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 5.88
Funders
- King Faisal Specialist Hospital and Research Centre
- Taif University